Immune Checkpoint Inhibitors Do Not Increase Short-Term Risk of Hypertension in Cancer Patients: a Systematic Literature Review and Meta-Analysis.
Shintaro MinegishiSho KinguchiNobuyuki HoritaHo NamkoongAlexandros BriasoulisTomoaki IshigamiKouichi TamuraAkira NishiyamaYuichiro Yanonull nullPublished in: Hypertension (Dallas, Tex. : 1979) (2022)
ICI initiation was not associated with short-term risk of hypertension in cancer patients, and the association was similar regardless of concomitant treatment with other anticancer drugs.